|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 2,484.50 JPY | -0.20% |
|
+2.03% | +11.96% |
| 07-14 | ViiV expands licence to allow generic HIV treatment production for low-income countries | RE |
| 07-10 | Shionogi & Co., Ltd. Implements Stibo Systems MDM Solution | CI |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
Compared values
| Sector | Change | 5d. change | 1st Jan change | 1-year change | 5-years change | Capi. | ST | MT | LT | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| SHIONOGI & CO., LTD. | Other Pharmaceuticals | -0.20% | +2.03% | +11.96% | +12.20% | +17.92% | 14.22B |  |  | |
Technical Rankings Surperformance
- Stock Market
- Equities
- 4507 Stock
- Charts Shionogi & Co., Ltd.
- Comparison Chart
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition
Stay in the current country edition